• Explore /
  • Poster
  • / A phase 2 multi-arm study of magrolimab in combination with docetaxel in patients with locally advanced or metastatic solid tumors: ELEVATE Lung and UC.

A phase 2 multi-arm study of magrolimab in combination with docetaxel in patients with locally advanced or metastatic solid tumors: ELEVATE Lung and UC.

Abstract Poster

Authors

Vivek Subbiah

Vivek Subbiah

The University of Texas MD Anderson Cancer Center, Houston, TX

Vivek Subbiah , Ulka N. Vaishampayan , Sonam Puri , Shivaani Kummar , Julia Martinez Perez , Antoine Italiano , Jiang Shao , Riya Bathia , Aoife Sills , Sandip Pravin Patel

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer—Non-Small Cell Metastatic

Track

Lung Cancer

Sub Track

Metastatic Non–Small Cell Lung Cancer

Clinical Trial Registration Number

NCT04827576

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr TPS9142)

DOI

10.1200/JCO.2023.41.16_suppl.TPS9142

Abstract #

TPS9142

Poster Bd #

128b

Abstract Disclosures

Similar Posters

First Author: Natalie Rainey

First Author: A. Dimitrios Dimitrios Colevas

First Author: Vivek Subbiah

First Author: Wang Qu